Joincare Pharmaceutical Group Industry Co.,Ltd. (F9L.F)
Frankfurt · EUR · Healthcare · Drug Manufacturers - Specialty & Generic
€6.85 (+0.74%) as of
Key statistics
- Market cap
- 1.25B
- P/E (TTM)
- 8.56
- EPS (TTM)
- 0.80
- Dividend yield
- 18.08%
- 52-week range
- 6.35 – 12.60
- Revenue (TTM)
- 13.41B
- Profit margin
- 8.43%
About Joincare Pharmaceutical Group Industry Co.,Ltd.
Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China and internationally. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle's American ginseng tea, and YikeTie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Shenzhen, China
- Employees
- 13,575
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.